Liesch J M, Hensens O D, Zink D L, Goetz M A
Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.
J Antibiot (Tokyo). 1988 Jul;41(7):878-81. doi: 10.7164/antibiotics.41.878.
Asperlicins B (1, C31H29N5O5), C (2, C25H18N4O2), D (3, C25H18N4O2), and E (4, C25H18N4O3) are novel cholecystokinin antagonists produced by Aspergillus alliaceus. The structures of these compounds have been determined by 1H NMR and MS analysis.
蒜曲霉产生的曲霉利菌素B(1,C₃₁H₂₉N₅O₅)、C(2,C₂₅H₁₈N₄O₂)、D(3,C₂₅H₁₈N₄O₂)和E(4,C₂₅H₁₈N₄O₃)是新型的胆囊收缩素拮抗剂。这些化合物的结构已通过¹H NMR和MS分析确定。